manufactures, markets and/or distributes more than 118 drugs in the United States. Non-US country and region specific information is not available on this page. Chloroquine autophagy concentration Plaquenil acetaminophen interaction HYDERABAD, India and PRINCETON, N. J. — Dr. Reddy’s Laboratories announced the launch of hydroxychloroquine sulfate tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil hydroxychloroquine sulfate tablets, in the. U. S. market, approved by the U. S. Food and Drug Administration. Dr. Reddys, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives. Dr. Reddy’s Laboratories, Inc. Product Name and Strength Hydroxychloroquine Sulfate Tablets, USP 200 mg. 120 Belmont Dr. The launch follows approval of Hydroxychloroquine Sulfate tablets, a therapeutic equivalent generic version of Plaquenil, by the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a BSE filing. Dr Reddy's Laboratories today announced the launch of generic version of Plaquenil, used to treat malaria, lupus erythematosus, and rheumatoid arthritis, in the US. Dr reddy's laboratories hydroxychloroquine Dr Reddy's launches Plaquenil's generic version in US after., Dr Reddy’s - Multinational Pharmaceutical Company Plaquenil brand name costPlaquenil spanish Hydroxychloroquine Sulfate with NDC 43598-721 is a a human prescription drug product labeled by Dr. Reddy's Laboratories Inc. The generic name of Hydroxychloroquine Sulfate is hydroxychloroquine sulfate. The product's dosage form is tablet and is administered via oral form. Labeler Name Dr. Reddy's Laboratories Inc. NDC 43598-721 Hydroxychloroquine Sulfate. CPSIA Section 102 a1 Certification. Pill Identifier Hydroxychloroquine Sulfate - NDC 43598-721. Drugs Associated with Dr. Reddy's Laboratories, Inc. Dr. Reddy's Laboratories, Inc. manufactures, markets and/or distributes more than 118 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page. Dr. Reddy\'s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U. S. Market Business Wire Dr. Reddy’s Laboratories Ltd. BSE 500124, NSE DRREDDY, NYSE RDY, along with its subsidiaries together referred to as “Dr. Reddy’s” today announce Hydroxychloroquine Sulfate ” aka “Hydroxychloroquine Sulfate” is a human prescription drug product labeled by “Dr. Reddy's Laboratories Inc.”. This web page contains comprehensive information about NDC Code 43598-721-01.